Table 1.
Clinical indications | Definition |
---|---|
NS | 24-h urine protein ≥ 3.5 g with edema, accompanied by serum albumin < 30 g/L, hyperlipidemia |
Nephritic syndrome | 24-h urine protein between 1.5 and 3.5 g with hematuria, with or without high blood pressure and edema |
ANS | Abrupt onset of hematuria, hypertension, edema, oliguria and reduced eGFR |
RPGN | Acute nephritic syndrome with acute deteriorated renal function such as a twofold increase in serum creatinine concentration or a decrease in creatinine clearance by 50% |
AUA | Microscopic hematuria and /or subnephrotic proteinuria with no clinical symptoms or signs |
AKI | SCr increase ≥ 0.3 mg/dl (≥ 26.5 umol/L) within 48 h or SCr increased by ≥ 1.5 times the baseline value within the prior 7 days or urinary output < 0.5 ml/kg/h for 6 h |
CKD | eGFR < 60 mL/min/1.73 m2 or > 60 mL/min/1.73 m2 with urine albumin creatinine ratio (UACR) > 3 mg/mmol for ≥ 3 months |
NS nephrotic syndrome, ANS acute nephritic syndrome, RPGN rapidly progressive renal glomerulonephritis, AUA asymptomatic urinary abnormalities, AKI acute kidney injury, CKD chronic kidney disease.